Back
Bechtle AG Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
38
BECTY
Bechtle AG
Last Price:
$6.84
Seasonality Move:
-5.11%
Sell
40
SRPT
Sarepta Therapeutics
Last Price:
$107.18
Seasonality Move:
1.75%
Sell
38
Bechtle AG (BECTY)
is a Sell
Is Bechtle AG a Buy, Sell or Hold?
-
The current Bechtle AG [BECTY] share price is $6.84. The Score for BECTY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
BECTY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $105.35. The Score for SRPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BECTY Stock Price Chart
What is Bechtle AG's stock price today?
-
The Bechtle AG share price today is $6.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BECTY is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $105.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BECTY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 76.43 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.3 - 6.72) | Buy |
Bollinger Bands (100): | (6.46 - 7.68) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.26 | Sell |
Relative Strength Index (14 RSI): | 30.3 | Sell |
Chaikin Money Flow: | 907164 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.77 - 118.35) | Sell |
Bollinger Bands (100): | (114.01 - 127.71) | Sell |
BECTY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.8 | Buy |
20-day SMA: | 6.56 | Buy |
50-day SMA: | 6.6 | Buy |
200-day SMA: | 8.05 | Sell |
8-day EMA: | 6.77 | Buy |
20-day EMA: | 6.64 | Buy |
50-day EMA: | 6.71 | Buy |
200-day EMA: | 7.77 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 109.87 | Sell |
20-day SMA: | 113.62 | Sell |
50-day SMA: | 119.39 | Sell |
200-day SMA: | 128.44 | Sell |
8-day EMA: | 109.65 | Sell |
20-day EMA: | 113.1 | Sell |
50-day EMA: | 117.33 | Sell |
200-day EMA: | 123.21 | Sell |
Bechtle AG Earnings Growth & BECTY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
Bechtle AG Technical Analysis
Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |